{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-155448","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2023-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.004127+00:00","generated_at":"2026-06-14T12:50:02.905549+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Soleno Therapeutics stockholders approve all six proposals at 2023 annual meeting","bullets":["Elected Ernest Mario and Birgitte Volck as Class II directors with ~64.8% and ~66.7% of votes cast, respectively.","Ratified Marcum LLP as independent auditor for fiscal 2023 (5,977,682 for, 113,718 against).","Advisory say-on-pay approved (4,019,358 for, 111,424 against); board accepted three-year frequency.","Approved amended 2014 Equity Incentive Plan (3,874,198 for, 254,424 against).","Approved issuance of shares upon exercise of warrants from May 8, 2023 private placement (4,003,720 for, 132,021 against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-155448","json":"https://secwatch.observer/filing/0001193125-23-155448.json","markdown":"https://secwatch.observer/filing/0001193125-23-155448.md","text":"https://secwatch.observer/filing/0001193125-23-155448.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/d515984d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T12:50:02.905549+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"32b94d65ffd61cdf2cf026fd91d07b3f65eda9bc","claim":"SOLENO THERAPEUTICS INC shareholders approved Approval of Named Executive Officer compensation on an advisory basis at the 2023-05-25 meeting.","evidence_excerpt":"Votes For Votes Against Abstentions Broker Non-Votes 4,019,358 111,424 15,486 1,949,693","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm","confidence":0.98,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"6bed27b31039b23edbabc6e8e34ead53ffcc1fb4","claim":"SOLENO THERAPEUTICS INC shareholders approved Ratification of appointment of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-05-25 meeting.","evidence_excerpt":"Votes For Votes Against Abstentions Broker Non-Votes 5,977,682 113,718 4,561 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm","confidence":0.98,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"793beed6f3c74ece1e405afebc6e47f80cfedb40","claim":"SOLENO THERAPEUTICS INC shareholders approved Approval of frequency of stockholder votes on Named Executive Officer compensation on an advisory basis at the 2023-05-25 meeting.","evidence_excerpt":"Votes For Every 3 Years Votes for Every 2 Years Votes for Every 1 Years Abstentions Broker Non-Votes 2,234,536 18,934 1,865,518 27,280 1,949,693","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm","confidence":0.97,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"8befd37d56ee41ed4daf773dae944e8441892329","claim":"SOLENO THERAPEUTICS INC shareholders approved Approval of issuance of shares upon exercise of warrants sold in private placement on May 8, 2023 at the 2023-05-25 meeting.","evidence_excerpt":"Votes For Votes Against Abstentions Broker Non-Votes 4,003,720 132,021 10,527 1,949,693","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm","confidence":0.97,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"91e07e8c3055500bd4326a58cfd1f57e9bfca820","claim":"SOLENO THERAPEUTICS INC shareholders approved Approval of Amended and Restated 2014 Equity Incentive Plan at the 2023-05-25 meeting.","evidence_excerpt":"Votes For Votes Against Abstentions Broker Non-Votes 3,874,198 254,424 17,646 1,949,693","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm","confidence":0.98,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"b7160cda570f3131810828b4a20d54be20a67b0b","claim":"SOLENO THERAPEUTICS INC shareholders approved Election of two Class II directors at the 2023-05-25 meeting.","evidence_excerpt":"Nominee Votes For Votes Withheld Percent of Voted Broker Non-Votes Ernest Mario 3,950,528 195,740 64.8 % 1,949,693 Birgitte Volck 4,066,365 79,903 66.7 % 1,949,693","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484565/000119312523155448/0001193125-23-155448-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}